Home » Topics » BioWorld Science

BioWorld Science
RSS

IDP Discovery Pharma describes new VEGF inhibitors

July 28, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents G12C mutant GTPase KRAS inhibitors

July 28, 2022

New galectin-3 inhibitors synthesized at Galecto Biotech

July 28, 2022

Shionogi discovers 5-HT2A receptor antagonists and/or inverse agonists

July 28, 2022

Medshine Discovery identifies new CREBBP and/or p300 inhibitors

July 28, 2022

ZyVersa receives grant to assess potential of IC-100 to block neuroinflammation in Parkinson's

July 27, 2022

Vitamin B6 benzohydrazide platinum(II) complexes overcome cisplatin resistance in tumors

July 27, 2022

Amubarvimab/romlusevimab retains neutralizing activity against live Omicron subvariants

July 27, 2022

Monoclonal antibody pairs "zipper" to target cancer

July 27, 2022

New MAT2A inhibitors discovered at Jiangsu Simcere Pharmaceutical R&D

July 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...